ESOPMay 29, 2026, 04:31 PM
Zevra Therapeutics Grants 33,000 Stock Options to Four New Employees
AI Summary
Zevra Therapeutics, Inc. announced it has granted options to purchase an aggregate of 33,000 shares of its common stock to four new employees. These "Inducement Awards" are issued under the Company's 2023 Employment Inducement Award Plan and vest over four years. The grants were approved by the Compensation Committee as a material inducement for the individuals to join Zevra, in accordance with Nasdaq rules. Zevra is a commercial-stage company focused on developing life-changing therapeutics for rare diseases.
Key Highlights
- Zevra Therapeutics granted options to purchase 33,000 shares of common stock.
- The options were awarded to four new employees as inducement awards.
- Awards are part of the Company's 2023 Employment Inducement Award Plan.
- Each inducement award vests over four years, with 25% on the first anniversary.
- The grants were approved by the Compensation Committee.
- Awards comply with Nasdaq Rule 5635(c)(4) for employment inducement.
Price Impact
More from ZVRA